Microbiota and reproducibility of rodent models

Lab Animal

Volumn 46, Issue 4, 2017, Pages 114-122

  Franklin, Craig L ^a   Ericsson, Aaron C ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL HUSBANDRY; ANIMAL MODEL; DISEASE MODEL; HELICOBACTER; HELICOBACTER INFECTION; INTESTINE FLORA; MICROBIOLOGY; REPRODUCIBILITY; RODENT; VETERINARY;

ANIMAL HUSBANDRY; ANIMALS; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; HELICOBACTER; HELICOBACTER INFECTIONS; MODELS, ANIMAL; REPRODUCIBILITY OF RESULTS; RODENTIA;

EID: 85016195616     PISSN: 00937355     EISSN: 15484475     Source Type: Journal    
DOI: 10.1038/laban.1222     Document Type: Review

References (110)

1. Whitman, W.B., Coleman, D.C. & Wiebe, W.J. Prokaryotes: the unseen majority. Proc. Natl. Acad. Sci. USA 95, 6578-6583 (1998).
2. Clemente, J.C., Ursell, L.K., Parfrey, L.W. & Knight, R. The impact of the gut microbiota on human health: an integrative view. Cell 148, 1258-1270 (2012).
3. De vos, W.M. & De vos, E.A. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr. Rev. 70 (Suppl. 1), S45-S56 (2012).
4. Ridaura, V.K. et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013).
5. Collins, F.S. & Tabak, L.A. Policy: NiH plans to enhance reproducibility. Nature 505, 612-613 (2014).
6. Perrin, S. Preclinical research: Make mouse studies work. Nature 507, 423-425 (2014).
7. Ma, B.W. et al. Routine habitat change: a source of unrecognized transient alteration of intestinal microbiota in laboratory mice. PLoS ONE 7, e47416 (2012).
8. Sof, M.H. et al. Ph of drinking water infuences the composition of gut microbiome and type 1 diabetes incidence. Diabetes 63, 632-644 (2014).
9. Sasada, T. et al. Chlorinated water modulates the development of colorectal tumors with chromosomal instability and gut microbiota in Apc-defcient mice. PLoS ONE 10, e0132435 (2015).
10. Jin, U.H. et al. Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities. Mol. Pharmacol. 85, 777-788 (2014).
11. Turnbaugh, P.J., Backhed, F., Fulton, L. & Gordon, J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223 (2008).
12. Ooi, J.H. et al. Dominant effects of the diet on the microbiome and the local and systemic immune response in mice. PLoS ONE 9, e86366 (2014).
13. Schloss, P.D. & Handelsman, J. Status of the microbial census. Microbiol. Mol. Biol. Rev. 68, 686-691 (2004).
14. Turnbaugh, P.J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031 (2006).
15. Barnard, D.E., Lewis, S.M., Teter, B.B. & Thigpen, J.E. Open-and closed-formula laboratory animal diets and their importance to research. J. Am. Assoc. Lab. Anim. Sci. 48, 709-713 (2009).
16. Denning, T.L. et al. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J. Immunol. 187, 733-747 (2011).
17. Hufeldt, M.R., Nielsen, D.S., Vogensen, F.K., Midtvedt, T. & Hansen, A.K. Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors. Comp. Med. 60, 336-347 (2010).
18. Ivanov, I.I. et al. Specifc microbiota direct the differentiation of iL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337-349 (2008).
19. Ericsson, A.C. et al. Effects of vendor and genetic background on the composition of the fecal microbiota of inbred mice. PLoS ONE 10, e0116704 (2015).
20. Chung, H. et al. Gut immune maturation depends on colonization with a host-specifc microbiota. Cell 149, 1578-1593 (2012).
21. Friswell, M.K. et al. Site and strain-specifc variation in gut microbiota profles and metabolism in experimental mice. PLoS ONE 5, e8584 (2010).
22. Biasucci, G. et al. Mode of delivery affects the bacterial community in the newborn gut. Early Hum. Dev. 86 (Suppl. 1), 13-15 (2010).
23. Dominguez-Bello, M.G. et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA 107, 11971-11975 (2010).
24. Lotz, M. et al. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J. Exp. Med. 203, 973-984 (2006).
25. Antonopoulos, D.A. et al. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun. 77, 2367-2375 (2009).
26. Bohnhoff, M., Drake, B.L. & Miller, C.P. Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc. Soc. Exp. Biol. Med. 86, 132-137 (1954).
27. Hill, D.A. et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 3, 148-158 (2010).
28. Hoentjen, F. et al. Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene defcient mice. Gut 52, 1721-1727 (2003).
29. Meynell, G.G. Some factors affecting the resistance of mice to oral infection by Salmonella typhimurium. Proc. R. Soc. Med. 48, 916-918 (1955).
30. Robinson, C.J. & Young, V.B. Antibiotic administration alters the community structure of the gastrointestinal micobiota. Gut Microbes 1, 279-284 (2010).
31. Sekirov, I. et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect. Immun. 76, 4726-4736 (2008).
32. Bongers, G. et al. Interplay of host microbiota, genetic perturbations, and infammation promotes local development of intestinal neoplasms in mice. J. Exp. Med. 211, 457-472 (2014).
33. Rakoff-Nahoum, S., Paglino, J., Eslami-varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microfora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
34. Cryan, J.F. & Dinan, T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev. Neurosci. 13, 701-712 (2012).
35. O'Mahony, S.M. et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry 65, 263-267 (2009).
36. Robosky, L.C. et al. Metabonomic identifcation of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats. Toxicol. Sci. 87, 277-284 (2005).
37. Rohde, CM. et al. Metabonomic evaluation of Schaedler altered microfora rats. Chem. Res. Toxicol. 20, 1388-1392 (2007).
38. Yang, I. et al. Intestinal microbiota composition of interleukin-10 defcient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitis. PLoS ONE 8, e70783 (2013).
39. Li, Y. et al. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis 33, 1231-1238 (2012).
40. Mai, V., Colbert, L.H., Perkins, S.N., Schatzkin, A. & Hursting, S.D. Intestinal microbiota: a potential diet-responsive prevention target in ApcMin mice. Mol. Carcinog. 46, 42-48 (2007).
41. Begley, C.G. & Ellis, L.M. Drug development: Raise standards for preclinical cancer research. Nature 483, 531-533 (2012).
42. Hutchinson, L. & Kirk, R. High drug attrition rates-where are we going wrong? Nat Rev. Clin. Oncol. 8, 189-190 (2011).
43. Prinz, F., Schlange, T. & Asadullah, K. Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev. Drug Discov. 10, 712 (2011).
44. Kilkenny, C, Browne, W.J., Cuthill, I.C., Emerson, M. & Altman, D.G. Improving bioscience research reporting: the ARRive guidelines for reporting animal research. PLoS Biol. 8, e1000412 (2010).
45. Bleich, A. & Hansen, A.K. Time to include the gut microbiota in the hygienic standardisation of laboratory rodents. Comp. Immunol. Microbiol. Infect. Dis. 35, 81-92 (2012).
46. Ward, J.M., Anver, M.R., Haines, D.C. & Benveniste, R.E. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am. J. Pathol. 145, 959-968 (1994).
47. Ward, J.M. et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl. Cancer Inst. 86, 1222-1227 (1994).
48. Boutin, S.R. et al. Hepatic temporal gene expression profling in Helicobacter hepaticus-infected A/JCr mice. Toxicol. Pathol. 32, 678-693 (2004).
49. Fox, J.G. et al. Helicobacter hepaticus sp. Nov, a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J. Clin. Microbiol. 32, 1238-1245 (1994).
50. Hailey, J.R. et al. Impact of Helicobacter hepaticus infection in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies. Toxicol. Pathol. 26, 602-611 (1998).
51. Foltz, C.J. et al. Spontaneous infammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 3, 69-78 (1998).
52. Kullberg, M.C. et al. Helicobacter hepaticus triggers colitis in specifc-pathogen-free interleukin-10 (iL-10)-defcient mice through an iL-12-and gamma interferon-dependent mechanism. Infect. Immun. 66, 5157-5166 (1998).
53. Chin, E.Y., Dangler, C.A., Fox, J.G. & Schauer, D.B. Helicobacter hepaticus infection triggers infammatory bowel disease in T cell receptor alphabeta mutant mice. Comp. Med. 50, 586-594 (2000).
54. Engle, S.J. et al. Elimination of colon cancer in germ-free transforming growth factor beta 1-defcient mice. Cancer Res. 62, 6362-6366 (2002).
55. Cahill, R.J. et al. Infammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect. Immun. 65, 3126-3131 (1997).
56. Dieleman, L.A. et al. Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-defcient mice. Infect. Immun. 68, 5107-5113 (2000).
57. Fox, J.G. Helicobacter bilis: bacterial provocateur orchestrates host immune responses to commensal fora in a model of infammatory bowel disease. Gut 56, 898-900 (2007).
58. Jergens, A.E. et al. Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut 56, 934-940 (2007).
59. Jiang, H.Q., Kushnir, N., Thurnheer, M.C, Bos, N.A. & Cebra, J.J. Monoassociation of SCiD mice with Helicobacter muridarum, but not four other enterics, provokes iBD upon receipt of T cells. Gastroenterology 122, 1346-1354 (2002).
60. Liu, Z. et al. Helicobacter bilis colonization enhances susceptibility to Typhlocolitis following an infammatory trigger. Dig. Dis. Sci. 56, 2838-2848 (2011).
61. Myles, M.H., Dieckgraefe, B.K., Criley, J.M. & Franklin, C.L. Characterization of cecal gene expression in a differentially susceptible mouse model of bacterial-induced infammatory bowel disease. Infamm. Bowel Dis. 13, 822-836 (2007).
62. Myles, M.H., Livingston, R.S., Livingston, B.A., Criley, J.M. & Franklin, C.L. Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis. Infect. Immun. 71, 3885-3893 (2003).
63. Ivanov, I.I. et al. Induction of intestinal Th17 cells by segmented flamentous bacteria. Cell 139, 485-498 (2009).
64. Lee, Y.K., Menezes, J.S., Umesaki, Y. & Mazmanian, S.K. Proinfammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 108 (Suppl. 1), 4615-4622 (2011).
65. Wu, H.J. et al. Gut-residing segmented flamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815-827 (2010).
66. Ericsson, A.C., Hagan, C.E., Davis, D.J. & Franklin, C.L. Segmented flamentous bacteria: commensal microbes with potential effects on research. Comp. Med. 64, 90-98 (2014).
67. Chudnovskiy, A. et al. Host-protozoan interactions protect from mucosal infections through activation of the infammasome. Cell 167, 444-456 e414, doi:10.1016/j.cell.2016.08.076 (2016).
68. Escalante, N.K. et al. The common mouse protozoa Tritrichomonas muris alters mucosal T cell homeostasis and colitis susceptibility. J. Exp. Med. 213, 2841-2850 (2016).
69. Tan, T.G. et al. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc. Natl. Acad. Sci. USA 113, e8141-e8150 (2016).
70. Zackular, J.P., Baxter, N.T., Chen, G.Y. & Schloss, P.D. Manipulation of the gut microbiota reveals role in colon tumorigenesis. Msphere 1: doi:10.1128/mSphere.00001-15 (2016).
71. Rahija, R.J. In The Mouse in Biomedical Research vol. 3 (eds J.G. Fox et al.) 217-233 (Academic Press, 2007).
72. Donohoe, D.R. et al. A gnotobiotic mouse model demonstrates that dietary fber protects against colorectal tumorigenesis in a microbiota-and butyrate-dependent manner. Cancer Discov. 4, 1387-1397 (2014).
73. Goodman, A.L. et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc. Natl. Acad. Sci. USA 108, 6252-6257 (2011).
74. Nguyen, T.L., Vieira-Silva, S., Liston, A. & Raes, J. How informative is the mouse for human gut microbiota research? Dis. Model. Mech. 8, 1-16 (2015).
75. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
76. Gaboriau-Routhiau, V. et al. The key role of segmented flamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689 (2009).
77. Helgeland, L., Vaage, J.T., Rolstad, B., Midtvedt, T. & Brandtzaeg, P. Microbial colonization infuences composition and T-cell receptor v beta repertoire of intraepithelial lymphocytes in rat intestine. Immunology 89, 494-501 (1996).
78. Macpherson, A.J. & Harris, N.L. Interactions between commensal intestinal bacteria and the immune system. Nat Rev. Immunol. 4, 478-485 (2004).
79. Umesaki, Y., Setoyama, H., Matsumoto, S. & Okada, Y. Expansion of alpha beta T-cell receptor-bearing intestinal intraepithelial lymphocytes after microbial colonization in germ-free mice and its independence from thymus. Immunology 79, 32-37 (1993).
80. Savage, D.C, Siegel, J.E., Snellen, J.E. & Whitt, D.D. Transit time of epithelial cells in the small intestines of germfree mice and ex-germfree mice associated with indigenous microorganisms. Appl. Environ. Microbiol. 42, 996-1001 (1981).
81. Chowdhury, S.R. et al. Transcriptome profling of the small intestinal epithelium in germfree versus conventional piglets. BMC Genomics 8, 215 (2007).
82. Hooper, L.V. et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881-884 (2001).
83. Backhed, F. et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101, 15718-15723 (2004).
84. Wikoff, W.R. et al. Metabolomics analysis reveals large effects of gut microfora on mammalian blood metabolites. Proc. Natl. Acad. Sci. USA 106, 3698-3703 (2009).
85. Mazmanian, S.K., Liu, C.H., Tzianabos, A.O. & Kasper, D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118 (2005).
86. Round, J.L. et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332, 974-977 (2011).
87. Kernbauer, E., Ding, Y. & Cadwell, K. An enteric virus can replace the benefcial function of commensal bacteria. Nature 516, 94-98 (2014).
88. Nell, S., Suerbaum, S. & Josenhans, C. The impact of the microbiota on the pathogenesis of iBD: lessons from mouse infection models. Nat. Rev. Microbiol. 8, 564-577 (2010).
89. Fritz, J.V., Desai, M.S., Shah, P., Schneider, J.G. & Wilmes, P. From meta-omics to causality: experimental models for human microbiome research. Microbiome 1, 14 (2013).
90. Schaedler, R.W., Dubos, R. & Costello, R. The development of the bacterial fora in the gastrointestinal tract of mice. J. Exp. Med. 122, 59-66 (1965).
91. Schaedler, R.W., Dubs, R. & Costello, R. Association of germfree mice with bacteria isolated from normal mice. J. Exp. Med. 122, 77-82 (1965).
92. Orcutt, R.P., Gianni, F.J. & Judge, R.J. Development of an "altered" Schaedler fora for NCi gnotobiotic rodents. Microecology and Therapy 17, 59 (1987).
93. Dewhirst, F.E. et al. Phylogeny of the defned murine microbiota: altered Schaedler fora. Appl. Environ. Microbiol. 65, 3287-3292 (1999).
94. Robertson, B.R. et al. Mucispirillum schaedleri gen. Nov., Sp. Nov., A spiral-shaped bacterium colonizing the mucus layer of the gastrointestinal tract of laboratory rodents. Int. J. Syst. Evol. Microbiol 55, 1199-1204 (2005).
95. Sarma-Rupavtarm, R.B., Ge, Z., Schauer, D.B., Fox, J.G. & Polz, M.F. Spatial distribution and stability of the eight microbial species of the altered schaedler fora in the mouse gastrointestinal tract. Appl. Environ. Microbiol. 70, 2791-2800 (2004).
96. Wannemuehler, M.J., Overstreet, A.M., Ward, D.V. & Phillips, G.J. Draft genome sequences of the altered schaedler fora, a defned bacterial community from gnotobiotic mice. Genome Announc. 2, e00287 (2014).
97. Macpherson, A.J. & McCoy, K.D. Standardised animal models of host microbial mutualism. Mucosal Immunol. 8, 476-486 (2015).
98. Belenguer, A. et al. Two routes of metabolic cross-feeding between Bifdobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl. Environ. Microbiol. 72, 3593-3599 (2006).
99. Pfeiffer, T. & Bonhoeffer, S. Evolution of cross-feeding in microbial populations. Am. Nat. 163, e126-e135 (2004).
100. Ericsson, A.C. & Franklin, C.L. Manipulating the gut microbiota: Methods and challenges. ILAR J. 56, 205-217 (2015).
101. Bel, S. et al. Reprogrammed and transmissible intestinal microbiota confer diminished susceptibility to induced colitis in TMF-/-mice. Proc. Natl. Acad. Sci. USA 111, 4964-4969 (2014).
102. Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228-231 (2010).
103. Garrett, W.S. et al. Communicable ulcerative colitis induced by T-bet defciency in the innate immune system. Cell 131, 33-45 (2007).
104. Couturier-Maillard, A. et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123, 700-711 10.1172/JCi62236 (2013).
105. Elinav, E. et al. NLRP6 infammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011).
106. Fuhrer, A. et al. Milk sialyllactose infuences colitis in mice through selective intestinal bacterial colonization. J. Exp. Med. 207, 2843-2854 (2010).
107. Turecki, G. & Meaney, M.J. Effects of the social environment and stress on glucocorticoid receptor gene methylation: A systematic review. Biol. Psychiatry 79, 87-96 (2016).
108. Beura, L.K. et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532, 512-516 (2016).
109. Reese, T.A. et al. Sequential infection with common pathogens promotes human-like immune gene expression and altered vaccine response. Cell Host Microbe 19, 713-719 (2016).
110. Weldon, L. et al. The gut microbiota of wild mice. PLoS ONE 10, e0134643 (2015).